CTT PHARMACEUTICAL (CTTH) CEO Buys 11,500 Shares

What Happened
The company's CEO reported a purchase of 11,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) on 2026-08-20. The Form 4 lists the transaction as 11,500 shares acquired at $0.04 per share, with a total value shown in the filing of $518. This was a purchase (transaction code P), which is generally viewed as a more bullish signal than a sale, though significance depends on size.

Key Details

• Transaction date: 2026-08-20
• Reported price: $0.04 per share; total reported value: $518 (per filing)
• Shares transacted: 11,500 acquired (transaction code P = Purchase; filing indicates open-market or private purchase)
• Shares owned after transaction: not disclosed in the public summary of the filing
• Footnotes/plans: no 10b5‑1 plan, tax withholding, or other special footnotes noted in the submitted details
• Filing timeliness: Form filed on 2026-08-20 (same day as the reported transaction), indicating a timely filing

Context
This purchase is relatively small in dollar terms (~$518 as reported), so it may carry limited information about the CEO’s view of the company compared with larger insider buys. Purchases are worth noting because insiders have direct knowledge, but retail investors should weigh trade size and overall insider ownership before drawing conclusions.